trial · primary record
TAK-226
Myelodysplastic Syndromes
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 42 |
| Primary completion | 2033-01-10 |
| Primary endpoint | Transfusion dependent (TD) cohort: Percentage of Participants Achieving Transfusion Independence (TI) for Greater Than or Equal to (>=) 8 Weeks from Baseline through Week 24 |
| Registry ID | NCT07319845 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:05.192Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07319845
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.